Advertisement
Screener

AXIM BIOTECHNOLOGIES, INC. (AXIM) Scorecard

2.8 / 5 stars · 68/120 Roast Me

AXIM BIOTECHNOLOGIES, INC. (AXIM) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
24/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseAXIM / S&P
-50.00% / 15.20%
LoseAXIM / S&P
AXIM unavailable / 15.00%
LoseAXIM / S&P
AXIM unavailable / 50.40%
2026-Q10/3 LoseAXIM / S&P
-45.45% / -4.33%
LoseAXIM / S&P
AXIM unavailable / 11.30%
LoseAXIM / S&P
AXIM unavailable / 27.70%
2025-Q41/3 WinAXIM / S&P
120.00% / 2.65%
LoseAXIM / S&P
AXIM unavailable / 9.00%
LoseAXIM / S&P
AXIM unavailable / 13.40%
2025-Q30/3 LoseAXIM / S&P
-16.67% / 8.12%
LoseAXIM / S&P
AXIM unavailable / 4.61%
LoseAXIM / S&P
AXIM unavailable / 13.45%
2025-Q21/3 WinAXIM / S&P
50.00% / 10.94%
LoseAXIM / S&P
AXIM unavailable / 4.83%
LoseAXIM / S&P
AXIM unavailable / 10.63%
2025-Q11/3 WinAXIM / S&P
100.00% / -4.27%
LoseAXIM / S&P
AXIM unavailable / 4.98%
LoseAXIM / S&P
AXIM unavailable / 10.57%
2024-Q40/3 LoseAXIM / S&P
-60.00% / 2.41%
LoseAXIM / S&P
AXIM unavailable / 5.25%
LoseAXIM / S&P
AXIM unavailable / 6.15%
2024-Q30/3 LoseAXIM / S&P
-50.00% / 5.89%
LoseAXIM / S&P
AXIM unavailable / 5.89%
LoseAXIM / S&P
AXIM unavailable / 6.11%
2024-Q21/3 LoseAXIM / S&P
-16.67% / 4.28%
WinAXIM / S&P
254.56% / 5.38%
LoseAXIM / S&P
-51.46% / 5.12%
2024-Q11/3 LoseAXIM / S&P
-36.84% / 10.56%
WinAXIM / S&P
424.51% / 5.71%
LoseAXIM / S&P
-12.37% / 5.59%
2023-Q42/3 LoseAXIM / S&P
-9.52% / 11.69%
WinAXIM / S&P
348.07% / 6.81%
WinAXIM / S&P
11.32% / 7.78%
2023-Q31/3 LoseAXIM / S&P
-34.38% / -3.27%
WinAXIM / S&P
462.93% / 7.52%
LoseAXIM / S&P
-123.85% / -5.03%
2023-Q22/3 WinAXIM / S&P
39.13% / 8.74%
WinAXIM / S&P
102.54% / 9.50%
LoseAXIM / S&P
-134.29% / -8.57%
2023-Q10/3 LoseAXIM / S&P
-17.86% / 7.50%
LoseAXIM / S&P
-41.49% / 10.77%
LoseAXIM / S&P
-131.67% / -15.69%
2022-Q40/3 LoseAXIM / S&P
-72.00% / 7.56%
LoseAXIM / S&P
-85.32% / 11.88%
LoseAXIM / S&P
-131.67% / -17.99%
2022-Q31/3 WinAXIM / S&P
78.57% / -4.88%
LoseAXIM / S&P
AXIM unavailable / 13.47%
LoseAXIM / S&P
AXIM unavailable / -1.41%
2022-Q20/3 LoseAXIM / S&P
-55.91% / -16.10%
LoseAXIM / S&P
AXIM unavailable / 13.71%
LoseAXIM / S&P
AXIM unavailable / 11.04%
2022-Q10/3 LoseAXIM / S&P
-70.67% / -4.60%
LoseAXIM / S&P
AXIM unavailable / 15.97%
LoseAXIM / S&P
AXIM unavailable / 42.23%
2021-Q40/3 LoseAXIM / S&P
-22.68% / 11.03%
LoseAXIM / S&P
AXIM unavailable / 15.00%
LoseAXIM / S&P
AXIM unavailable / 96.40%
2021-Q30/3 LoseAXIM / S&P
-40.36% / 0.58%
LoseAXIM / S&P
AXIM unavailable / 10.77%
LoseAXIM / S&P
AXIM unavailable / 69.42%
2021-Q21/3 WinAXIM / S&P
40.15% / 8.55%
LoseAXIM / S&P
AXIM unavailable / 6.58%
LoseAXIM / S&P
AXIM unavailable / 51.81%
2021-Q11/3 WinAXIM / S&P
54.73% / 6.17%
LoseAXIM / S&P
AXIM unavailable / -1.06%
LoseAXIM / S&P
AXIM unavailable / 7.39%
2020-Q40/3 LoseAXIM / S&P
-28.78% / 12.15%
LoseAXIM / S&P
AXIM unavailable / -3.72%
LoseAXIM / S&P
AXIM unavailable / -33.42%
2020-Q31/3 WinAXIM / S&P
126.02% / 8.93%
LoseAXIM / S&P
AXIM unavailable / -2.04%
LoseAXIM / S&P
AXIM unavailable / -27.10%
2020-Q21/3 WinAXIM / S&P
99.26% / 20.54%
LoseAXIM / S&P
AXIM unavailable / -0.46%
LoseAXIM / S&P
AXIM unavailable / -27.11%
2020-Q10/3 LoseAXIM / S&P
-63.01% / -19.60%
LoseAXIM / S&P
AXIM unavailable / 3.47%
LoseAXIM / S&P
AXIM unavailable / -14.75%
2019-Q40/3 LoseAXIM / S&P
-43.85% / 9.07%
LoseAXIM / S&P
AXIM unavailable / 5.36%
LoseAXIM / S&P
AXIM unavailable / 2.99%
2019-Q31/3 LoseAXIM / S&P
-20.73% / 1.70%
WinAXIM / S&P
1442.14% / 5.02%
LoseAXIM / S&P
AXIM unavailable / 0.21%
2019-Q21/3 LoseAXIM / S&P
-44.97% / 4.30%
WinAXIM / S&P
494.79% / 6.64%
LoseAXIM / S&P
AXIM unavailable / 8.65%
2019-Q12/3 WinAXIM / S&P
98.67% / 13.65%
WinAXIM / S&P
359.31% / 8.12%
LoseAXIM / S&P
AXIM unavailable / 14.29%
2018-Q41/3 LoseAXIM / S&P
-59.55% / -13.52%
WinAXIM / S&P
311.19% / 9.05%
LoseAXIM / S&P
AXIM unavailable / 18.23%
2018-Q30/3 LoseAXIM / S&P
-34.49% / 7.71%
LoseAXIM / S&P
-0.51% / 10.21%
LoseAXIM / S&P
AXIM unavailable / 19.06%
2018-Q20/3 LoseAXIM / S&P
-16.89% / 3.43%
LoseAXIM / S&P
7.85% / 9.03%
LoseAXIM / S&P
AXIM unavailable / 14.46%
2018-Q10/3 LoseAXIM / S&P
-63.19% / -0.76%
LoseAXIM / S&P
-16.40% / 7.68%
LoseAXIM / S&P
AXIM unavailable / 12.46%
2017-Q41/3 WinAXIM / S&P
38.06% / 6.64%
LoseAXIM / S&P
1.09% / 7.03%
LoseAXIM / S&P
AXIM unavailable / 13.82%
2017-Q30/3 LoseAXIM / S&P
-33.30% / 4.48%
LoseAXIM / S&P
-11.81% / 5.68%
LoseAXIM / S&P
AXIM unavailable / 17.57%
2017-Q20/3 LoseAXIM / S&P
-25.29% / 3.09%
LoseAXIM / S&P
-29.07% / 4.83%
LoseAXIM / S&P
AXIM unavailable / 17.74%
2017-Q11/3 WinAXIM / S&P
54.54% / 6.07%
LoseAXIM / S&P
-18.16% / 3.67%
LoseAXIM / S&P
AXIM unavailable / 13.32%
2016-Q41/3 WinAXIM / S&P
3682.61% / 3.82%
LoseAXIM / S&P
-4.23% / 2.09%
LoseAXIM / S&P
AXIM unavailable / 7.05%
2016-Q31/3 LoseAXIM / S&P
-37.67% / 3.85%
WinAXIM / S&P
49.05% / 0.20%
LoseAXIM / S&P
AXIM unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricAXIM total returnS&P 500 Total Return Index
Total return-40.00%20.78%
Annualized return-40.00%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricAXIM total returnS&P 500 Total Return Index
Total return-99.53%83.14%
Annualized return-65.79%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricAXIM total returnS&P 500 Total Return Index
Total return-99.00%319.30%
Annualized return-36.90%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.